Aarey Drugs & Pharmaceuticals Limited (BOM:524412)
India flag India · Delayed Price · Currency is INR
110.10
-5.35 (-4.63%)
At close: Nov 16, 2026

BOM:524412 Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
4,2014,7234,7394,0264,1904,929
Revenue Growth
-1.90%-0.35%17.73%-3.91%-15.01%40.27%
Gross Profit
161.13176.75118.23206.4150.87208.51
Operating Income
52.7857.8151.1797.7166.92100.27
Net Income
39.6639.6840.2446.8437.7165.55
Earnings Per Share
1.301.391.411.841.482.72
EPS Growth
3.65%-1.42%-23.37%24.32%-45.59%-2.36%

Cash & Debt

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
13.5633.9832.2928.911.241.92
Total Debt
562.92582.93435.49313.52377.18141.63
Net Cash (Debt)
-549.36-548.95-403.2-284.63-365.94-139.71
Net Cash Growth
------
Net Cash Per Share
-18.06-19.29-14.17-11.20-14.36-5.80

Cash Flow & CapEx

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
-192.95101.39103-29.94-12.814.99
Capital Expenditures
-124.11-124.11-52.04-7.22-10.44-22.01
Free Cash Flow
-317.06-22.7250.96-37.16-23.25-17.03
Free Cash Flow Growth
------

Margins

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
3.84%3.74%2.50%5.13%3.60%4.23%
Operating Margin
1.26%1.22%1.08%2.43%1.60%2.03%
Pretax Margin
1.04%1.15%1.29%1.33%1.43%2.04%
Profit Margin
0.94%0.84%0.85%1.16%0.90%1.33%
FCF Margin
-7.55%-0.48%1.07%-0.92%-0.56%-0.34%

Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingNov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
84.6936.4923.4226.7615.9316.03
P/FCF Ratio
--18.49---
PS Ratio
0.750.310.200.310.140.21